Tecentriq's Small-Cell Lung Cancer Success Takes Edge Off Roche's IO Position

Roche's combination of Tecentriq with chemotherapy is ahead of rivals in first-line SCLC and has been filed with the US...

More From BioPortfolio on "Tecentriq's Small-Cell Lung Cancer Success Takes Edge Off Roche's IO Position"